BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15042903)

  • 1. [The treatment of ductal carcinoma in situ (DCIS) of the breast].
    Voogd AC; Ernst MF
    Ned Tijdschr Geneeskd; 2004 Mar; 148(10):505-6; author reply 506. PubMed ID: 15042903
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ductal carcinoma in situ of the breast].
    Procaccini E; Ruggiero R; Docimo G; Iovino F; Procaccini F; Gili S; Lo Schiavo F
    G Chir; 2006; 27(1-2):40-4. PubMed ID: 16608632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dilemma of DCIS.
    Morrow M; O'Sullivan MJ
    Breast; 2007 Dec; 16 Suppl 2():S59-62. PubMed ID: 17714949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of ductal carcinoma in situ (DCIS) of the breast].
    Tjalma WA
    Ned Tijdschr Geneeskd; 2004 Mar; 148(10):507; author reply 507. PubMed ID: 15042904
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.
    Meijnen P; Oldenburg HS; Peterse JL; Bartelink H; Rutgers EJ
    Ann Surg Oncol; 2008 Jan; 15(1):235-43. PubMed ID: 17987342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductal carcinoma in situ (DCIS) of the breast--a therapeutic dilemma.
    van Dongen JA; Bartelink H; Fentiman IS; Peterse JL
    Eur J Surg Oncol; 1987 Apr; 13(2):123-5. PubMed ID: 3030824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is excision alone adequate treatment for low-risk ductal carcinoma-in-situ of the breast?
    Solin LJ
    J Clin Oncol; 2006 Mar; 24(7):1017-9. PubMed ID: 16461780
    [No Abstract]   [Full Text] [Related]  

  • 8. Margin width as the sole determinant of local recurrence after breast conservation in patients with ductal carcinoma in situ of the breast.
    Macdonald HR; Silverstein MJ; Lee LA; Ye W; Sanghavi P; Holmes DR; Silberman H; Lagios M
    Am J Surg; 2006 Oct; 192(4):420-2. PubMed ID: 16978941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal carcinoma in situ of the breast: our experience.
    Ruggiero R; Procaccini E; Sanguinetti A; Cremone C; Gili S; Docimo G; Docimo L; Sparavigna L; Gubitosi A; Parmeggiani D; Avenia N
    G Chir; 2009 Mar; 30(3):121-4. PubMed ID: 19351465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ductal carcinoma in situ of the breast (DCIS) under 40: a specific management?].
    Cutuli B
    Gynecol Obstet Fertil; 2008 Jun; 36(6):705-6. PubMed ID: 18539513
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast cancer-specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast.
    Lee LA; Silverstein MJ; Chung CT; Macdonald H; Sanghavi P; Epstein M; Holmes DR; Silberman H; Ye W; Lagios MD
    Am J Surg; 2006 Oct; 192(4):416-9. PubMed ID: 16978940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.
    Mazouni C; Peintinger F; Wan-Kau S; Andre F; Gonzalez-Angulo AM; Symmans WF; Meric-Bernstam F; Valero V; Hortobagyi GN; Pusztai L
    J Clin Oncol; 2007 Jul; 25(19):2650-5. PubMed ID: 17602071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary?
    Yerushalmi R; Sulkes A; Mishaeli M; Neumann A; Dinerman M; Sulkes J; Rizel S; Yarom N; Gutman H; Fenig E
    Neoplasma; 2006; 53(6):507-10. PubMed ID: 17167720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local recurrences after conservative treatment of ductal carcinoma-in-situ of the breast without radiotherapy: the effect of age.
    Schouten van der Velden AP; Peeters PH; Koot VC; Hennipman A
    Ann Surg Oncol; 2006 Jul; 13(7):990-8. PubMed ID: 16788762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DCIS prognostic markers: a few new candidates emerge.
    Nelson NJ
    J Natl Cancer Inst; 2010 May; 102(9):588-90. PubMed ID: 20427428
    [No Abstract]   [Full Text] [Related]  

  • 16. [In situ carcinomas of the breast: clinical features and therapeutic strategies].
    Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M
    Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ or localized breast cancer--how much treatment is needed?
    Swain SM
    N Engl J Med; 1993 Jun; 328(22):1633-4. PubMed ID: 8387638
    [No Abstract]   [Full Text] [Related]  

  • 18. Local recurrences after different treatment strategies for ductal carcinoma in situ of the breast: a population-based study in the East Netherlands.
    Schouten van der Velden AP; van Vugt R; Van Dijck JA; Leer JW; Wobbes T
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):703-10. PubMed ID: 17544591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ductal carcinoma in situ: through a glass, darkly.
    Lagios MD; Silverstein MJ
    Ann Surg Oncol; 2008 Jan; 15(1):16-7. PubMed ID: 18043977
    [No Abstract]   [Full Text] [Related]  

  • 20. Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? Yes. Radiation therapy, an important component of breast conserving treatment for patients with ductal carcinoma in situ of the breast.
    Buchholz TA; Haffty BG; Harris JR
    J Surg Oncol; 2007 Jun; 95(8):610-3. PubMed ID: 17221862
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.